Evidence map›Paper›PMID 37376759›Full record

ArticleHuman gene therapy2023

An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain Vasculature.

Servio H Ramirez, Jonathan F Hale, Siobhan McCarthy, Christian L Cardenas, Kalpani N Udeni Galpayage Dona, Killian S Hanlon, Eloise Hudry, Demitri De La Cruz, Carrie Ng, Sabyasachi Das and 6 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Human gene therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Towards precision medicine for brain arteriovenous malformations.The Journal of clinical investigation · 2026
    Review
  3. Article
  4. Cerebral capillary computation.American journal of physiology. Cell physiology · 2026
    Review
  5. Article
  6. Review
  7. Integrin α8-Mediated Pericyte Morphogenesis Controls Blood-Brain Barrier Integrity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  8. Article
  9. Article
  10. Neurophotonics · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

  • Erratum issued
    2023
5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Servio H RamirezDepartment of Pathology and Laboratory Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
Jonathan F HaleDepartment of Pathology and Laboratory Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
Siobhan McCarthyCenter for Genomic Medicine; Massachusetts General Hospital, Boston, Massachusetts, USA.
Christian L CardenasHarvard Medical School, Boston, Massachusetts, USA.
Kalpani N Udeni Galpayage DonaDepartment of Pathology and Laboratory Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
Killian S HanlonHarvard Medical School, Boston, Massachusetts, USA.
Eloise HudryHarvard Medical School, Boston, Massachusetts, USA.
Demitri De La CruzHarvard Medical School, Boston, Massachusetts, USA.
Carrie NgHarvard Medical School, Boston, Massachusetts, USA.
Sabyasachi DasCenter for Genomic Medicine; Massachusetts General Hospital, Boston, Massachusetts, USA.
Diane M NguyenDepartment of Neurology; Massachusetts General Hospital, Boston, Massachusetts, USA.
Josette NammourHarvard Medical School, Boston, Massachusetts, USA.
Rachel E BennettHarvard Medical School, Boston, Massachusetts, USA.
Allison M AndrewsDepartment of Pathology and Laboratory Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
Patricia L MusolinoCenter for Genomic Medicine; Massachusetts General Hospital, Boston, Massachusetts, USA.
Casey A MaguireHarvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0001-8681-5179
Harvard University · USShriners Hospitals for Children - Philadelphia · USMassachusetts General Hospital · US

Funding

Pilot Projects Core (PPC)P30DA013429 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI Munir Gunes Kutlu · 2000 to 2026
$34.6M
Modeling and Therapeutic Approaches for Genetic VasculopathiesR01NS125353 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MARK E LINDSAY, Patricia L Musolino · 2022 to 2026
$3.5M
The role of cannabinoids in the regulation of the blood brain barrier in the context of NeuroHIV and anti-retroviral therapyR01DA052970 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI PERSIDSKY, YURI, RAMIREZ, SERVIO HEYBERT · 2021 to 2025
$3.0M
HIV and Cocaine Drive Bone-Marrow Blood (BMB) Barrier Dysfunction and Altered Hematopoietic Stem Cell (HSC) Differentiation Leading to Cardiovascular DiseaseDP2DA056172 · NIDA · UNIVERSITY OF FLORIDA · PI ANDREWS, ALLISON MICHELLE · 2022 to 2022
$2.3M
Microvascular Stress as a Pathway to Neurodegeneration in Alzheimer'sR01AG071567 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Rachel Elise Bennett · 2022 to 2026
$2.1M
Effects of ABCD1 Deficiency on Endothelial Function and Permeability to Leukocytes in Cerebral X-linked AdrenoleukodystrophyR01NS117575 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MUSOLINO, PATRICIA L · 2020 to 2024
$2.0M
Enhanced gene delivery for CNS and sensory disordersR01DC017117 · NIDCD · MASSACHUSETTS GENERAL HOSPITAL · PI MAGUIRE, CASEY A · 2019 to 2023
$1.8M
Innovative In-Situ Imaging Techniques for the Visualization of CNS associated HIV reservoirs in the Context of Substance AbuseR61DA058397 · NIDA · UNIVERSITY OF FLORIDA · PI Allison Michelle Andrews, Pooja Jain · 2023 to 2026
$1.7M
Role of Patrolling Monocytes in Cerebral Vascular Repair during HIV/Substance AbuseK01DA046308 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ANDREWS, ALLISON MICHELLE · 2019 to 2023
$749k
Targeting Chronic Senescence to Restore Tissue Homeostasis in Myhre syndromeR21AR080778 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI LINDSAY, MARK E, MOU, HONGMEI · 2022 to 2023
$386k
NIAMS NIH HHS R21 AR080778NIA NIH HHS R01 AG071567NIDA NIH HHS DP2 DA056172NIDA NIH HHS K01 DA046308NIDA NIH HHS P30 DA013429NIDA NIH HHS R01 DA052970NIDCD NIH HHS R01 DC017117NINDS NIH HHS R01 NS117575NINDS NIH HHS R01 NS125353
6 · The paper itself

Abstract

Neurodegeneration and cerebrovascular disease share an underlying microvascular dysfunction that may be remedied by selective transgene delivery. To date, limited options exist in which cellular components of the brain vasculature can be effectively targeted by viral vector therapeutics. In this study, we characterize the first engineered adeno-associated virus (AAV) capsid mediating high transduction of cerebral vascular pericytes and smooth muscle cells (SMCs). We performed two rounds of

Indexed as

CapsidDependovirusBrainCapsid ProteinsGenetic VectorsHumansMyocytes, Smooth MusclePericytesTransduction, GeneticCapsid Proteinsadeno-associated virus vectorpericytessmooth muscle cells

Identifiers

PMID37376759
PMCPMC10457656
OpenAlexW4382203606

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.